<DOC>
	<DOCNO>NCT00415636</DOCNO>
	<brief_summary>The purpose study evaluate safety tolerability IC83/LY2603618 treatment cancer .</brief_summary>
	<brief_title>Safety Tolerability IC83/LY2603618 Administered After Pemetrexed 500 mg/m2 Every 21 Days Patients With Cancer</brief_title>
	<detailed_description />
	<mesh_term>Pemetrexed</mesh_term>
	<criteria>Has least one lesion evaluate RECIST Has fully recover toxicity due following : Has life expectancy least 3 month . Negative serum pregnancy test . Is pregnant breastfeeding . Is woman childbearing potential unwilling use approve , effective mean contraception accord institution 's standard . Is man childbearing potential unwilling use approve , effective mean contraception accord institution 's standard . Has history brain metastasis , unless adequately treat without radiologic evidence progressive disease least 3 month completion therapy . Has know active infection .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2010</verification_date>
</DOC>